Pro CLB (540703)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.48: the market price of ₹9.96 is barely half the stated book value of ₹20.90.
• Piotroski F-Score of 5/9 suggests some financial fundamentals are not uniformly poor, though it is not a strong signal.
• No debt-to-equity ratio is reported, so the balance sheet is not visibly burdened by high leverage.

Concerns

• Latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, meaning there is no active earnings engine.
• ROE at -4.83% and ROCE at -6.72% indicate the book value is being eroded, not enhanced.
• Current trading price of ₹9.96 is below the stated 52-week low of ₹23.23, signalling possible distress, stale data, or extreme illiquidity.
• Promoter holding is unavailable and dividend yield is zero, creating transparency and capital-allocation concerns.

AI Analysis

Let me look at Pro CLB through a Graham-Buffett lens. A ₹5 Cr microcap in consulting services, trading at ₹9.96 against a book value of ₹20.90 – that is a P/B of 0.48. At first glance, it looks like a classic asset play. But the old sage would ask: what earnings can the asset produce? The answer is very little. Return on equity is -4.83%, and ROCE is -6.72%; the latest quarter shows zero sales and zero net profit. A company with no current revenue and negative returns is a melting ice cube, not a bargain. The 500% profit growth is a meaningless base effect when the absolute numbers are zero. Book value is only worth something if management can earn a reasonable return or unlock value through dividends or buybacks; with no dividend and no promoter data, you are relying on faith. The 52-week range of ₹23.23 to ₹48.90, with the price now below that band, hints at a severe loss of trust or possibly illiquid trading. Piotroski score of 5/9 is passable, but it cannot overcome zero sales. Graham would say: buy a dollar for 50 cents only if the asset truly is a dollar. Here the asset is already shrinking due to negative ROE. I would not call this a business; it is a possible liquidation exercise, and minority shareholders may not see that value. Keep it on a watchlist, but do not treat a low P/B as a green light.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer